![David Jin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Jin
Director of Finance/CFO at
AVENUE THERAPEUTICS, INC.
Net worth: 60 590 $ as of 30/05/2026
Profile
David Jin is currently Independent Director at Mustang Bio, Inc. since 2024.
Holds director position at Crystalys Therapeutics, Inc. Serves as Treasurer at Urica Therapeutics, Inc., Cyprium Therapeutics, Inc., Cellvation, Inc., and Helocyte, Inc. since 2022.
Acts as Secretary, Chief Operating & Financial Officer at Avenue Therapeutics, Inc. since 2022.
Functions as CFO & Head-Corporate Development at Fortress Biotech, Inc. since 2020.
Formerly Director at Barings LLC from 2017 to 2020.
Served as Director-Corporate Development at Sorrento Therapeutics, Inc. from 2016 to 2017.
Was Vice President-Healthcare Investment Banking at FBR & Co. from 2013 to 2016.
Completed undergraduate education at Northwestern University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 21/06/2026 | 21,571 ( 0.06% ) | 60 399 $ | 30/05/2026 | |
| 29/12/2025 | 286 ( 0% ) | 192 $ | 30/05/2026 | |
| 24/11/2025 | 0 ( -.--% ) | - $ | 30/05/2026 |
David Jin active positions
| Companies | Position | Start |
|---|---|---|
| AVENUE THERAPEUTICS, INC. | Director of Finance/CFO | 10/05/2022 |
| FORTRESS BIOTECH, INC. | Director of Finance/CFO | 15/08/2022 |
| MUSTANG BIO, INC. | Director/Board Member | 22/10/2024 |
Cyprium Therapeutics, Inc.
 Cyprium Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for the treatment of menkes disease and related copper metabolism disorders | Treasurer | 31/07/2022 |
Urica Therapeutics, Inc. | Treasurer | 31/07/2022 |
Helocyte, Inc.
 Helocyte, Inc. BiotechnologyHealth Technology Operates as a clinical stage company that develops novel immunotherapies for the prevention and treatment of cancer and infectious disease | Treasurer | 31/07/2022 |
Cellvation, Inc.
 Cellvation, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cellular therapeutics for treatment of traumatic brain injury | Treasurer | 31/07/2022 |
Former positions of David Jin
| Companies | Position | End |
|---|---|---|
Barings LLC
 Barings LLC Investment ManagersFinance Barings? investment decisions across all asset classes incorporate a comprehensive analysis that uses or combines top-down and/or bottom-up approaches to investment analysis. The firm utilizes economic, fundamental, technical/cyclical, and quantitative analyses, along with a sound understanding of both macro drivers and micro considerations in its investment decision-making process and to manage risk. They invest in a variety of fixed income and financing instruments across various industries as well as credit qualities and maturities in North America, Europe, Latin America, Africa/Middle East, and the Asia-Pacific region. Barings manages portfolios of public equity securities and equity-related securities of issuers of all sizes. The firm has teams focused on three alternative investment sectors: Real Estate, Private Equity & Real Assets, and Funds & Co-Investments. | Director/Board Member | 30/04/2020 |
| SORRENTO THERAPEUTICS, INC. | Corporate Officer/Principal | 30/06/2017 |
| ░░░ ░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of David Jin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
44
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Barings LLC
Barings LLC Investment ManagersFinance Barings? investment decisions across all asset classes incorporate a comprehensive analysis that uses or combines top-down and/or bottom-up approaches to investment analysis. The firm utilizes economic, fundamental, technical/cyclical, and quantitative analyses, along with a sound understanding of both macro drivers and micro considerations in its investment decision-making process and to manage risk. They invest in a variety of fixed income and financing instruments across various industries as well as credit qualities and maturities in North America, Europe, Latin America, Africa/Middle East, and the Asia-Pacific region. Barings manages portfolios of public equity securities and equity-related securities of issuers of all sizes. The firm has teams focused on three alternative investment sectors: Real Estate, Private Equity & Real Assets, and Funds & Co-Investments. | Finance |
Fortress Biotech, Inc.
 Fortress Biotech, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and biotechnology products | Health Technology |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FBR & Co.
 FBR & Co. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Sorrento Therapeutics, Inc.
 Sorrento Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical and commercial stage biopharmaceutical company that develops treatments for cancer, infectious disease and pain | Health Technology |
Avenue Therapeutics, Inc.
 Avenue Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops and commercializes therapies for neurological diseases | Health Technology |
Helocyte, Inc.
Helocyte, Inc. BiotechnologyHealth Technology Operates as a clinical stage company that develops novel immunotherapies for the prevention and treatment of cancer and infectious disease | Health Technology |
Mustang Bio, Inc.
 Mustang Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops novel immunotherapy''s | Health Technology |
Cyprium Therapeutics, Inc.
Cyprium Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for the treatment of menkes disease and related copper metabolism disorders | Health Technology |
Cellvation, Inc.
Cellvation, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cellular therapeutics for treatment of traumatic brain injury | Health Technology |
Urica Therapeutics, Inc. |
- Stock Market
- Insiders
- David Jin
